Literature DB >> 4098291

Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins.

G Virella, M F Lopes-Virella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4098291      PMCID： PMC1712708     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  30 in total

1.  The laboratory diagnosis of macroglobulinaemia, with special reference to starch-gel electrophoresis.

Authors:  E A BUTLER; F V FLYNN; H HARRIS; E B ROBSON
Journal:  Lancet       Date:  1961-08-05       Impact factor: 79.321

2.  Human serum macroglobulins and dissociation units. I. Physicochemical properties.

Authors:  H F DEUTSCH; J I MORTON
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

3.  Simple paper electrophoretic method for dectecting macroglobulinaemia.

Authors:  P LEDER
Journal:  Nature       Date:  1962-03-17       Impact factor: 49.962

4.  Dissociation, reaggregation, and subunit structure studies of some human gamma-M-globulins.

Authors:  T Suzuki; H F Deutsch
Journal:  J Biol Chem       Date:  1967-06-10       Impact factor: 5.157

5.  On the significance of the heterogeneity in molecular size of human serum gamma A-globulins.

Authors:  J P Vaerman; H H Fudenberg; C Vaerman; W J Mandy
Journal:  Immunochemistry       Date:  1965-09

6.  Fragmentation of immunoglobulin during storage.

Authors:  G E Connell; R H Painter
Journal:  Can J Biochem       Date:  1966-03

7.  Isolation of the monomeric subunit of immunoglobulin M with its interchain disulfide bonds intact.

Authors:  J E Morris; F P Inman
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

8.  Demonstration of molecular size differences between closely related antigens by a simple gel diffusion tes.

Authors:  G Virella
Journal:  Experientia       Date:  1969-11-15

9.  Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

Authors:  M Meltzer; E C Franklin
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

10.  SUBCLASSES OF HUMAN GAMMA-2-GLOBULIN BASED ON DIFFERENCES IN THE HEAVY POLYPEPTIDE CHAINS.

Authors:  W D TERRY; J L FAHEY
Journal:  Science       Date:  1964-10-16       Impact factor: 47.728
View more
  9 in total

1.  Salivary immunoglobulins in a patient with IgA deficiency.

Authors:  I M Coelho; M T Pereira; G Virella; R A Thompson
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

2.  Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

Authors:  R Bluestone; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

3.  Structural characterization of immunoglobulins contained in polyacrylamide gels.

Authors:  G Virella; M M de Freitas
Journal:  Experientia       Date:  1973-02-15

4.  Preparative block electrophoresis using Sephadex G-25.

Authors:  G Virella
Journal:  Experientia       Date:  1973-04-15

5.  Degradation of IgG3 monoclonal proteins during storage and in the presence of a thiol (DL-penicillamine).

Authors:  G Virella
Journal:  Experientia       Date:  1971-01-15

6.  IgG heavy chain sub-classes in mixed cryoglobulins.

Authors:  J J Cream; A Howard; G Virella
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

7.  Structural characterization of a human monoclonal IgA protein.

Authors:  R M Parkhouse; G Virella; R R Dourmashkin
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

8.  D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?

Authors:  A P Andonopoulos; E Terzis; E Tsibri; C A Papasteriades; T Papapetropoulos
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

9.  alpha-Mercaptopropionyl-glycine influence on the in vitro proliferative response of human lymphocytes.

Authors:  G Semenzato; A Pezzutto; G Amadori; R Raimondi; G Gasparotto
Journal:  Experientia       Date:  1979-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.